PDCD1 and neuroblastoma: Therefore, to better understand why anti-PD1 treatment was ineffective against idMMR neuroblastoma tumors, we decided to examine the immune features of idMMR neuroblastoma tumors that can impact their response to anti-PD1 treatment.